COVID-19
Conditions
Brief summary
The study is a prospective clinical cohort study of consecutive patients hospitalized at all hospitals of greater Copenhagen with a laboratory confirmed diagnosis of COVID-19. The investigators aim to examine if continuous ECG monitoring can be used to understand the contribution of COVID-19 infection in the acute phase to the development of cardiac arrhythmias, especially focusing on cardiovascular outcomes. In all patients included, the investigators aim to examine if continuous ECG monitoring - alone and in combination with biomarkers - can be used to detect early signs of cardiac complications and predict long-term risk of cardiovascular morbidity and mortality following COVID-19 infection.
Interventions
ECG monitoring
Sponsors
Study design
Eligibility
Inclusion criteria
* All patients hospitalized at hospitals of greater Copenhagen area and Zealand with a laboratory confirmed diagnosis of COVID-19 \> 18 years of age.
Exclusion criteria
* Persons not able to cooperate * Persons unable to understand and sign informed consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| In-hospital mortality during hospitalization and a confirmed COVID-19 diagnosis | 4 months |
| Incident intensive care unit admission during hospitalization and a confirmed COVID-19 diagnosis | 4 months |
Secondary
| Measure | Time frame |
|---|---|
| Incident pulmonary embolism during hospitalization and a confirmed COVID-19 diagnosis | 4 months |
| Incident cardiac arrest during hospitalization and a confirmed COVID-19 diagnosis | 4 months |
| Incident hypoxic respiratory failure during hospitalization and a confirmed COVID-19 diagnosis | 4 months |
Countries
Denmark